Home/Pipeline/Innovative Drug R&D Programs

Innovative Drug R&D Programs

Oncology, Metabolic Diseases

Phase 1/2Active

Key Facts

Indication
Oncology, Metabolic Diseases
Phase
Phase 1/2
Status
Active
Company

About China Resources Pharmaceutical Group

As a subsidiary of the state-owned China Resources Group, China Resources Pharmaceutical Group is a major player in China's healthcare sector, focusing on the research, development, production, and distribution of pharmaceutical products. The company has established a comprehensive business model encompassing pharmaceutical manufacturing, distribution, and retail pharmacy chains. Its strategic direction leverages its extensive distribution network and manufacturing capabilities to capitalize on China's growing healthcare market, while also pursuing innovation through its R&D pipeline.

View full company profile